Share Price | Muromachi Chemicals, Inc. Stock Analysis & Recommendation

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

Compare Muromachi Chemicals, Inc. with Similar Stocks

Medrx Co., Ltd.Ribomic, Inc.Kubota Pharmaceutical Holdings Co. Ltd.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

The company is Net-Debt Free

The company is Net-Debt Free

High Debt company with Weak Long Term Fundamental Strength

Positive results in May 26

With ROCE of 18.74%, it has a attractive valuation with a 1.30 Enterprise value to Capital Employed

Underperformed the market in the last 1 year

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

JPY 3,686 Million (Micro Cap)

P/E

9.00

Industry P/E

Dividend Yield

0.00%

Debt Equity

0.22

Return on Equity

14.67%

Price to Book

1.32

Revenue and Profits:

Net Sales:

2,189 Million

(Quarterly Results - May 2026)

Net Profit:

-175 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

1.15%

6 Months

10.38%

1 Year

29.47%

2 Years

5.12%

3 Years

8.74%

4 Years

-31.92%

5 Years

0.0%

Muromachi Chemicals, Inc. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

38.68%

EBIT Growth (5y)

29.95%

EBIT to Interest (avg)

19.11

Debt to EBITDA (avg)

1.48

Net Debt to Equity (avg)

0.24

Sales to Capital Employed (avg)

1.56

Tax Ratio

35.06%

Dividend Payout Ratio

41.38%

Pledged Shares

Institutional Holding

ROCE (avg)

15.13%

ROE (avg)

16.53%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.37

EV to EBIT

6.95

EV to EBITDA

5.39

EV to Capital Employed

1.30

EV to Sales

0.59

PEG Ratio

1.16

Dividend Yield

ROCE (Latest)

18.74%

ROE (Latest)

14.67%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bearish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Bullish

Moving Averages

Mildly Bearish (Daily)

KST

Mildly Bullish

Bullish

Dow Theory

Mildly Bearish

OBV

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot

No data for shareholding present.

Shareholding Compare (%holding)

No data for shareholding present.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - May'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended May 2026 is 20.68% vs -5.22% in May 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended May 2026 is -2,198.68% vs -105.44% in May 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "May'26",
        "May'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2,189.30",
          "val2": "1,814.10",
          "chgp": "20.68%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "251.90",
          "val2": "136.70",
          "chgp": "84.27%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "10.50",
          "val2": "9.00",
          "chgp": "16.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-397.00",
          "val2": "-78.90",
          "chgp": "-403.17%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-174.70",
          "val2": "-7.60",
          "chgp": "-2,198.68%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "89.80%",
          "val2": "48.90%",
          "chgp": "4.09%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - May'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended May 2026 is 17.86% vs 4.46% in May 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended May 2026 is -32.45% vs -26.92% in May 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "May'26",
        "May'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "7,840.90",
          "val2": "6,653.00",
          "chgp": "17.86%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "933.90",
          "val2": "593.90",
          "chgp": "57.25%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "45.50",
          "val2": "29.00",
          "chgp": "56.90%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-396.90",
          "val2": "-77.40",
          "chgp": "-412.79%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "163.00",
          "val2": "241.30",
          "chgp": "-32.45%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "94.80%",
          "val2": "65.00%",
          "chgp": "2.98%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]